Fundraising Fox
/Companies
Sign in

BiomEdit

Fishers, US · Founded 2022 · Delaware corporation · 6 known investors

Find your way into BiomEdit

Sign up to see every warm intro you have to BiomEdit

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the BiomEdit team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

BiomEdit develops microbiome-based products for animal health using high-throughput microbiology and AI-powered predictive algorithms. The company applies synthetic biology techniques to modify microbial populations for therapeutic and agricultural applications.

AgTechAI & Machine LearningBiotech

Founders & leadership

BSBruce Schelkopf
Bruce SchelkopfChief Legal Officer (CLO) & Chief Administrative Officer (CAO), GC, Company Secretary, CIPO/COO/CCOBruce Schelkopf serves as Executive Officer at BiomEdit. He brings experience in global legal operations, intellectual property strategy, regulatory compliance, and business development across technology and pharmaceutical sectors.
ASAaron Schacht
Aaron SchachtChief Executive Officer and Board DirectorAaron Schacht has over 35 years of experience in life sciences and serves as CEO of BiomEdit. He previously held executive leadership roles at Elanco Animal Health, where he was involved in business development and M&A activities, and has been involved in founding and funding multiple venture-backed companies in the biotechnology sector.

Board

PJ
Patrick JamesBoard director
PC
Paul CasadyBoard director
BWBrett Wong
Brett WongBoard directorPrincipal at Anterra Capital
BB
Barbara BodemBoard director

Investors · 6

AgriZeroNZreported

How we know: funding news · agfundernews.com · Not right? Tell us

Anterra CapitalreportedAmsterdam · $20M

How we know: funding news · agfundernews.com · the VCSheet dataset · Not right? Tell us

Elevate VenturesreportedIndianapolis · $20K – $2M

How we know: funding news · agfundernews.com · Not right? Tell us

Also in the syndicate · 2

Betagro VenturesNutreco

Funding

SEC filings, press & company announcements

$16M disclosed across 1 of 2 rounds · 2025–2026

▶$16MraisedJun 2025 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bruce SchelkopfExecutive Officer
  • Patrick JamesDirector
  • Paul CasadyDirector
  • Brett WongDirector
  • Aaron SchachtExecutive Officer, Director
  • Barbara BodemDirector
Offering amount
$20M
Amount sold
$16M
Minimum investment
$25K
First sale
Apr 2025
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Viome Life SciencesViome offers at-home tests that analyze the gut and oral microbiome plus cellular blood samples using mRNA/metatranscriptomic sequencing, returning 70+ health scores (including biological age and inflammation) and personalized food and supplement recommendations. The direct-to-consumer service, analyzed in a CLIA-certified lab, is aimed at individuals seeking insights into digestion, metabolism, and overall wellness.

Companies working in the same space as BiomEdit.

In the news

BiomEdit Raises $18.4M in Series B Fundingfinsmes.com · Jul 2025

Frequently asked questions

What does BiomEdit do?
BiomEdit develops microbiome-based products for animal health using high-throughput microbiology and AI-powered predictive algorithms. The company applies synthetic biology techniques to modify microbial populations for therapeutic and agricultural applications.
Who are BiomEdit's investors?
BiomEdit's investors include Viking Global, AgriZeroNZ, Anterra Capital, Elevate Ventures.
How much funding has BiomEdit raised?
BiomEdit has disclosed $16M raised across 1 of its 2 known rounds.
Where is BiomEdit headquartered?
BiomEdit is headquartered in Fishers, US.